The rapid and widespread adoption of virtual care since the onset of the COVID-19 pandemic has accelerated the tipping point for virtual care technologies and presents us with a once in a generation opportunity to radically transform our healthcare system by moving to an approach that we call Polymorphic Medicine. Polymorphic Medicine represents a paradigm shift towards the next evolution of healthcare. If the first decade of the 21st century was characterized by the “systemization” of healthcare with the introduction of electronic medical records, and the last decade saw the rise of genomic-based personalized medicine, we are now on the cusp of transitioning to the next phase – a re-humanization of healthcare with the system oriented around the individual, enabled by IoT technology, and informed by advanced analytics. The time is now for a new type of healthcare, one that is focused on reducing the overall burden of disease at a population level and supporting a person to better manage their own health at an individual level. This requires a level of personal responsibility and accountability by the individual, accompanied by a legislative environment that prioritizes the promotion of health, while discouraging policies that undermine it. And it requires a systematic digital and cultural transformation in the way that healthcare is designed, delivered, and experienced. Virtual Care provides the vehicle to rethink our ideas about health and the treatment of disease. Polymorphic Medicine, when fully implemented with the needs and preferences of individuals at the center and where Institutions and technology serve them and those who care for them, is the path to success – less disease, suffering, and cost with greater health benefit and convenience. Virtual Care served by Polymorphic Medicine and enabled by IoT is more than a mere extension of current practices – it is the path to a fundamentally new approach and ultimate success.


Dr. Quinlan has a distinguished track record and deep experience in all major facets of healthcare, including medical practice, governance, medical insurance, and medical and administrative management of fully integrated delivery systems. He is CEO Emeritus of the Ochsner Health System, and has served in many capacities over the years, including Department Chair, Chief Medical Officer, CEO of the Ochsner Clinic, CEO of Ochsner International, Founder and Director of the Ochsner Center for Wellness and Health Policy, and CEO & Board member of the Ochsner Health System. As CEO from 2001-2012, he led Ochsner through the Katrina crisis. He was the past chair of the Ochsner Health Plan, the largest HMO in Louisiana, and is the lead director for the international insurance company, Pan-American Life Insurance Group. Dr. Quinlan has experience in mergers, acquisitions, startups, turnarounds and joint ventures. He received past national recognition from Healthcare magazine as “the most powerful physician executive in the US” and one of the 50 most influential leaders in US healthcare. He is a partner in the socially responsible, woman-owned CreditWorks which builds credit and financial wellness for those in need, and is a board member and partner in Pack4U, a disruptive care system for patients of high risk and complexity. His international experience includes the President’s Advisory Board for St. Georges University in Grenada, the International Advisory Board to the Saudi Ministry of Health for Health Transformation, and business development engagements in Mexico, Panama, Dominican Republic, and Saudi Arabia. Education: BA in Economics (Phi Beta Kappa w special honors in Economics) from the University of Texas – Austin; Fellowship to the LBJ School of Public Affairs – UT Austin; MD from the University of Texas Galveston; Dermatology Residency – University of Alabama, Birmingham; Board Certification in Dermatology; MS Health Administration from the College of St. Francis.